Error: Could not add to watchlist. X
+ Watchlist

Galectin Therapeutics Inc

GALTU:US
NASDAQ CM
USD
Volume
0
Previous Close
4.19
52Wk Range
3.77 - 10.01
Volume
0
Previous Close
4.19
52Wk Range
3.77 - 10.01
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
18.312
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates.
Address
4960 Peachtree Industrial Blvd
Norcross, GA 30071
United States
Phone
1-678-620-3186
Show More